‘Venom: Let There Be Carnage’ Courses Through Russia With Top Opening Day Of Pandemic, Best-Ever For Sony

Film

While it was busy ringing in the second best previews night of the pandemic era domestically, Sony’s Venom: Let There Be Carnage set a new record for the Culver City studio in Russia on Thursday. With a $3.04M day one on Thursday, the Tom Hardy-starrer bested the previous film’s $2.97M in the market, making it Sony’s best-ever Russia launch day and the biggest opening day for all movies during the pandemic era there.

Venom 2 is the only major title to release in Russia this weekend — James Bond pic No Time To Die travels there next Thursday, October 7, and Dune (which has been having a great ride in Russia) is in its third frame. Theater capacity in Russia varies by region; in Moscow, cinemas are capped at 50%.

Russia was ultimately the second best overall offshore market on the first Venom at $32.6M after China’s $269.1M, both at historical rates.

Continued release of this Andy Serkis-directed Venom begins on October 6 in Mexico and Brazil on October 7. Following that, Belgium, Korea, Italy, Spain, the UK and Middle East go the next week. After, it’s France on October 20; Germany and the Netherlands on October 21; Australia on November 25 and Japan on December 3.

Domestically, as Anthony reported earlier, Venom: Let There Be Carnage did a great $11.6M Thursday night from showtimes that began at 4PM across 3,500 theaters. That’s the second best during the pandemic after Disney/Marvel’s Black Widow. It’s also higher than the $10M the first Venom did in 2018 from showtimes that began at 5PM. 

The 2018 Venom finaled at $642.6M at the international box office and $856.1M globally.

Products You May Like

Articles You May Like

If You Go Out In the Woods Today: 5 Great SFF Books Set in the Forest
Boy George Was ‘Tearful’ Over Liam Payne’s Death, Regrets Prior Criticism
Gap shares surge as it raises guidance, touts ‘strong start’ to holiday
‘Animal House’ Star Tim Matheson Says He Was ‘Lucky’ Not to Be Cocaine Addict
Top Wall Street analysts are upbeat on these stocks for the long haul

Leave a Reply

Your email address will not be published. Required fields are marked *